Gidi Littwin, a veteran of Apple's Face ID team, has founded Hemispheric, a startup developing AI systems to analyze brain scans for early detection of conditions including depression, PTSD, and Parkinson's disease. The company aims to make diagnostic brain imaging as accessible and affordable as a blood test, leveraging AI to extract clinical insights from existing imaging data.

By applying computer vision and deep learning techniques honed at Apple to medical imaging, Hemispheric is attempting to democratize neurological diagnostics. The approach could reduce diagnostic latency and costs, particularly in underserved regions with limited access to specialized neurologists.

What This Means for Your Business

Healthcare systems and insurance providers should monitor Hemispheric's regulatory progress closely. If the platform achieves FDA clearance for diagnostic support, it could significantly reduce the cost and wait time for neurological screening, improving patient outcomes while lowering per-diagnosis costs. Early adopters in hospital networks and large medical practices could gain competitive advantages in preventive care. However, validate the clinical evidence carefully before adoption, as AI diagnostic tools remain highly regulated and liability concerns are substantial.